Amount$2M
SeriesStrategic
AnnouncedJan 8, 2024
Time since last round220 mo
SectorLife Sciences, Patient, Clinical Trials, Drug Development, Computational Biology, Pharmaceutical, Data
Sub-sectorArtificial Intelligence, Deep Learning
Weak
A weak or unusual round versus its peers.
Round size vs peers
Far below the typical Strategic round — well under the median.
Syndicate size
Single investor — limited external validation.
Insider conviction
All-new money — no prior investors re-upped.
Investor track record
A mix of established and emerging investors.
Heuristic read of round size vs peers, syndicate size, insider conviction, and investor track record. Not investment advice.
vs. Strategic rounds (48)
Round size distribution17th pct
smaller Strategic roundslarger
